Evidence suggests that catalytically cleaved PKCδ can phosphorylate p38 MAPK in smooth muscle cells [69, 70], fibroblasts [71], prostate cancer cells [72] and hepatic stellate cells [73]. The gene discussed is PRKCD; the disease is prostate cancer.